RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Legend Star
L

Legend Star portfolio

Legend Star has 2 portfolio companies on record at Recent Funding.

Type: Venture capital.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $52M.
Latest deal: Rgenta Therapeutics · Nov 29, 2022.
About this page

It is a venture capital firm based in Beijing, CN, founded in 2008. Its most recent investment on record is Rgenta Therapeutics's $52M Series A round in November 2022, alongside Lilly Asia Ventures, CICC, Kaitai Capital and 6 others. By category, its portfolio leans toward Health and bio (1) and Robotics and hardware (1).

About Legend Star

Firm type: Venture capital.
Headquarters: Beijing, CN.
Founded: 2008.
Stages: Pre-Seed, Seed, Series A.
Sectors: AI & Machine Learning, Biotech, Cloud Computing, Deep Tech, Digital Health, Energy, Healthtech, Media & Entertainment, Medical Devices, Mobility & Transportation, Quantum Computing, Robotics, Semiconductors, Space Tech.
Leads rounds: No.

What Legend Star invests in

How Legend Star invests

StageDealsCapital in rounds
Series A 1 100%$52M

Legend Star portfolio companies

CompanyRound with Legend StarTotal raisedLatest raise
RRgenta Therapeutics
Health and bio
Series A · $52M$52MNov 3, 2026
Series B+
TTujian Technology
Robotics and hardware
backerundisclosedSep 27, 2026
Seed

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name Legend Star. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Legend Star, which is a subset of its real portfolio. API: /api/v1/investors/legend-star (get a free API key). More: the most active VC firms and new venture capital funds.